Experimental HIV immune training research

Researchers at Zuckerberg San Francisco General Hospital have reported promising results from an experimental study aimed at training the immune system to control HIV without the need for daily antiretroviral drugs. Led by Dr. Steven Deeks, the study involved ten participants who received intensive treatments, including therapeutic vaccines and laboratory-produced antibodies.

Following the treatment, seven of the ten participants successfully kept the virus under control after ceasing their daily medication. While six participants maintained low viral levels for several months, one participant showed no detectable levels of the virus after more than 18 months.

Findings published in the journal Nature suggest this approach challenges the medical assumption that the virus inevitably rebounds when medication is suspended. However, researchers emphasize that the study was small-scale, lacked a control group, and is not currently a substitute for standard antiretroviral therapy. Further investigation is required before these methods can be established as standard clinical treatments.